These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
21. Pharmacology of fluperlapine compared with clozapine. Eichenberger E Arzneimittelforschung; 1984; 34(1A):110-3. PubMed ID: 6145425 [TBL] [Abstract][Full Text] [Related]
22. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents. Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931 [TBL] [Abstract][Full Text] [Related]
23. Interactions of clozapine, thioridazine, and mezilamine with oxotremorine on schedule-controlled responding. Leander JD Psychopharmacology (Berl); 1983; 80(1):29-30. PubMed ID: 6135236 [TBL] [Abstract][Full Text] [Related]
24. Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic. Devoto P; Flore G; Vacca G; Pira L; Arca A; Casu MA; Pani L; Gessa GL Psychopharmacology (Berl); 2003 Apr; 167(1):79-84. PubMed ID: 12632247 [TBL] [Abstract][Full Text] [Related]
25. The effect of catecholamine receptor antagonists on ethanol-induced locomotor stimulation. Liljequist S; Berggren U; Engel J J Neural Transm; 1981; 50(1):57-67. PubMed ID: 6110703 [TBL] [Abstract][Full Text] [Related]
26. Behavioral effects of clozapine: comparison with thioridazine, chlorpromazine, haloperidol and chlordiazepoxide in squirrel monkeys. Spealman RD; Kelleher RT; Goldberg SR; DeWeese J; Goldberg DM J Pharmacol Exp Ther; 1983 Jan; 224(1):127-34. PubMed ID: 6848739 [TBL] [Abstract][Full Text] [Related]
27. Permeability changes induced in the adrenergic neurone by reserpine. Giachetti A; Shore PA Biochem Pharmacol; 1970 May; 19(5):1621-6. PubMed ID: 4935769 [No Abstract] [Full Text] [Related]
28. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine. Arvanov VL; Wang RY J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680 [TBL] [Abstract][Full Text] [Related]
29. Blockade of intracranial self-stimulation by antipsychotic drugs: failure to correlate with central alpha-noradrenergic blockade. Zarevics P; Weidley E; Setler P Psychopharmacology (Berl); 1977 Aug; 53(3):283-8. PubMed ID: 19806 [TBL] [Abstract][Full Text] [Related]
30. Effects of clozapine in a selective muscarinic bioassay and on single cells of the rat hippocampus. Herrling PL; Misbach-Lesenne B Naunyn Schmiedebergs Arch Pharmacol; 1982 Jul; 320(1):20-5. PubMed ID: 7121608 [TBL] [Abstract][Full Text] [Related]
31. Octopamine receptors in the molluscan aortic bulb: effects of clozapine and chlordimeform. Dougan DF; Wade DN Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 82(1):193-7. PubMed ID: 2865061 [TBL] [Abstract][Full Text] [Related]
32. Interaction between clozapine and a lipophilic alpha 1-adrenergic agonist. Menon MK; Gordon LI; Fitten J Life Sci; 1988; 43(22):1791-804. PubMed ID: 2904633 [TBL] [Abstract][Full Text] [Related]
33. Clozapine: neuroendocrine studies of an atypical neuroleptic. Meltzer HY; Nash JF; Koenig JI; Gudelsky GA Clin Neuropharmacol; 1986; 9 Suppl 4():316-8. PubMed ID: 2882843 [No Abstract] [Full Text] [Related]
34. Clozapine blocks D-amphetamine-induced excitation of dopamine neurons in the ventral tegmental area. Shi WX; Zhang XY; Pun CL; Bunney BS Neuropsychopharmacology; 2007 Sep; 32(9):1922-8. PubMed ID: 17299514 [TBL] [Abstract][Full Text] [Related]
35. One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonists. Jiang LH; Kasser RJ; Altar CA; Wang RY J Pharmacol Exp Ther; 1990 Jun; 253(3):1198-205. PubMed ID: 1972751 [TBL] [Abstract][Full Text] [Related]
36. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763 [TBL] [Abstract][Full Text] [Related]
37. S-16924 [(R)-2-[1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]- pyrrolidin-3yl]-1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic with marked serotonin1A agonist properties: III. Anxiolytic actions in comparison with clozapine and haloperidol. Millan MJ; Brocco M; Gobert A; Schreiber R; Dekeyne A J Pharmacol Exp Ther; 1999 Mar; 288(3):1002-14. PubMed ID: 10027837 [TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of antipsychotic drugs on the Con A- and LPS-induced proliferative activity of mouse splenocytes: a possible mechanism of action. Basta-Kaim A; Budziszewska B; Jagła G; Nowak W; Kubera M; Lasoń W J Physiol Pharmacol; 2006 Jun; 57(2):247-64. PubMed ID: 16845229 [TBL] [Abstract][Full Text] [Related]
39. Antipsychotic drugs inhibit the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cells-an involvement of protein kinases. Basta-Kaim A; Budziszewska B; Jaworska-Feil L; Tetich M; Kubera M; Leśkiewicz M; Otczyk M; Lasoń W Neuropsychopharmacology; 2006 Apr; 31(4):853-65. PubMed ID: 16205782 [TBL] [Abstract][Full Text] [Related]